SAN FRANCISCO (MarketWatch) -- Nastech Pharmaceutical Co. said Friday it has submitted a response to the Food and Drug Administration's office of generic drugs regarding the potential for ...
BERGEN, Norway — British investigators presented strong evidence that using salmon nasal calcitonin is ineffective for treating patients with lumbar spinal stenosis. Phil Sell, FRCS, of University ...
Please provide your email address to receive an email when new articles are posted on . The FDA’s Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory ...
OTTAWA, July 31, 2012 /CNW/ - Health Canada is informing Canadians that it is assessing the possibility of an increased risk of cancer with long-term use of the drug calcitonin. Calcitonin is a ...
—Data Presented at ASBMR 2011 Annual Meeting Show Tarsa's Oral Calcitonin Tablet OSTORA™ Achieved Positive Results on Efficacy Endpoints— The ORACAL study was a Phase III multinational, randomized, ...
Oral recombinant calcitonin might be more effective than nasal spray calcitonin in women with postmenopausal osteoporosis, according to the ORACAL trial researchers. This 48-week randomized, ...
July 20, 2012 — The European equivalent of the US Food and Drug Administration (FDA) yesterday recommended withdrawing calcitonin nasal spray — indicated for treating osteoporosis in the European ...
Data showed oral drug licensed from Unigene was as good as nasal spray calcitonin at improving BMD. Tarsa Therapeutics reported positive data from a Phase III study evaluating its once-daily oral ...
Zavzpret is the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute to migraines. People who suffer from migraines will have another option to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback